Xylocor Therapeutics, Inc.

Xylocor Therapeutics, Inc. company information, Employees & Contact Information

Explore related pages

Xylocor Therapeutics, Inc. email format Xylocor Therapeutics, Inc. management contacts

Related company profiles:

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Company Details

Employees
14
Founded
-
Address
411 Swedeland Rd,
Phone
888-290-0081
Email
in****@****cor.com
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Website
xylocor.com
Keywords
King of Prussia.
HQ
King of Prussia, Pennsylvania
Competitors
Kardigan, Abcuro, Inc, Aviceda Therapeutics, Verdiva Bio, Normunity, Ouro Medicines, Newleos Therapeutics, Tenvie Therapeutics, Helicore Biopharma, Timberlyne Therapeutics.
Looking for a particular Xylocor Therapeutics, Inc. employee's phone or email?

Xylocor Therapeutics, Inc. Questions

News

First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease - Business Wire

First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease Business Wire

XyloCor doses first subject in Phase IIb trial of gene therapy candidate XC001 - Clinical Trials Arena

XyloCor doses first subject in Phase IIb trial of gene therapy candidate XC001 Clinical Trials Arena

XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease - Yahoo Finance

XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease Yahoo Finance

Jeito Capital leads $67.5 million (€64.4 million[1]) Series - GlobeNewswire

Jeito Capital leads $67.5 million (€64.4 million[1]) Series GlobeNewswire

XyloCor Therapeutics raises $67.5 million - The Pharma Letter

XyloCor Therapeutics raises $67.5 million The Pharma Letter

XyloCor Therapeutics: $67.5 Million (Series B) Raised For Advancing Clinical Development Of Gene Therapy In Cardiovascular Disease - Pulse 2.0

XyloCor Therapeutics: $67.5 Million (Series B) Raised For Advancing Clinical Development Of Gene Therapy In Cardiovascular Disease Pulse 2.0

XyloCor to ride $67M wave into mid-stage study for cardiovascular gene therapy - FirstWord Pharma

XyloCor to ride $67M wave into mid-stage study for cardiovascular gene therapy FirstWord Pharma

XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart - Cision News

XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart Cision News

XyloCor gene therapy hits goals, paving way for phase 3 in cardiovascular space with no current treatment - Fierce Biotech

XyloCor gene therapy hits goals, paving way for phase 3 in cardiovascular space with no current treatment Fierce Biotech

Positive News From Gene Therapy Trial Involving LVHN Angina Patient - Lehigh Valley Health Network

Positive News From Gene Therapy Trial Involving LVHN Angina Patient Lehigh Valley Health Network

XyloCor Therapeutics, SmartWise Enter License Agreement for Use of Extroducer - Contract Pharma

XyloCor Therapeutics, SmartWise Enter License Agreement for Use of Extroducer Contract Pharma

XyloCor taps SmartWise’s infusion device for gene therapy administration - Clinical Trials Arena

XyloCor taps SmartWise’s infusion device for gene therapy administration Clinical Trials Arena

French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics - EU-Startups

French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics EU-Startups

XyloCor reports positive data from refractory angina gene therapy - Clinical Trials Arena

XyloCor reports positive data from refractory angina gene therapy Clinical Trials Arena

Sofinnova, LSP lead $17M round for gene therapy player XyloCor - Fierce Biotech

Sofinnova, LSP lead $17M round for gene therapy player XyloCor Fierce Biotech

XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease - Business Wire

XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease Business Wire

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire

Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ GlobeNewswire

Companies like Xylocor Therapeutics, Inc.

Normunity logo - Similar company to Xylocor Therapeutics, Inc.

Normunity

24
Timberlyne Therapeutics logo - Similar company to Xylocor Therapeutics, Inc.

Timberlyne Therapeutics

13
Aviceda Therapeutics logo - Similar company to Xylocor Therapeutics, Inc.

Aviceda Therapeutics

39
Helicore Biopharma logo - Similar company to Xylocor Therapeutics, Inc.

Helicore Biopharma

7
Verdiva Bio logo - Similar company to Xylocor Therapeutics, Inc.

Verdiva Bio

53
Newleos Therapeutics logo - Similar company to Xylocor Therapeutics, Inc.

Newleos Therapeutics

19
Kardigan logo - Similar company to Xylocor Therapeutics, Inc.

Kardigan

108
Ouro Medicines logo - Similar company to Xylocor Therapeutics, Inc.

Ouro Medicines

16
Tenvie Therapeutics logo - Similar company to Xylocor Therapeutics, Inc.

Tenvie Therapeutics

32
Abcuro, Inc logo - Similar company to Xylocor Therapeutics, Inc.

Abcuro, Inc

53

Top Xylocor Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant